sts2687 | CLP Training Program

Drugging the Undruggable: Targeting FoxP3 by a Molecular Glue to Improve Anti-Cancer Immunity AND Drugging the Undruggable: Targeting FoxP3 by a Molecular Glue to Improve Anti-Cancer Immunity

Drugging the Undruggable: Targeting FoxP3 by a Molecular Glue to Improve Anti-Cancer Immunity AND Drugging the Undruggable: Targeting FoxP3 by a Molecular Glue to Improve Anti-Cancer Immunity

by sts2687 | May 8, 2024 | Events

Chemical Proteomic Approaches to Study Pharmacological Landscapes of T Cells

Chemical Proteomic Approaches to Study Pharmacological Landscapes of T Cells

by sts2687 | May 2, 2024 | Events

Engineering MS2 Bacteriophage Virus-Like Particle for Targeted Drug Delivery Applications And Elucidating the Ligandability of Cancer Acquired Cysteines

Engineering MS2 Bacteriophage Virus-Like Particle for Targeted Drug Delivery Applications And Elucidating the Ligandability of Cancer Acquired Cysteines

by sts2687 | Apr 23, 2024 | Events

From phenotypic screens to therapeutic targets for myelin repair and immunomodulation

From phenotypic screens to therapeutic targets for myelin repair and immunomodulation

by sts2687 | Apr 23, 2024 | Events

Harnessing DCAF16 for Targeted Degradation of Nuclear-Restricted Proteins in Cancer

Harnessing DCAF16 for Targeted Degradation of Nuclear-Restricted Proteins in Cancer

by sts2687 | Apr 5, 2024 | Events

« Older Entries

Next Entries »